TriLink BioTechnologies社 August TriLink Messenger
RESEARCH NEWS |
||||||
mRNA Vaccine for Protection Against Peanut Allergy Anaphylaxis | ||||||
Peanut is one of the most prevalent food allergens, affecting ~2% of people worldwide, and is the leading source of food-induced severe allergic reactions, including fatal anaphylaxis. Peanut allergy, which typically manifests during childhood, has increased over the past three decades, tripling to 1.2 million children in the United States. Let's explore mRNA vaccines for protection against peanut allergy anaphylaxis in our blog. |
||||||
Upcoming Events |
||||||
mRNA Process Development and Manufacturing Summit |
||||||
The 2nd mRNA Process Development & Manufacturing Summit (Sep 26 - Sep 28) returns to Boston as the most comprehensive and technical industry-dedicated forum, to address key industry bottlenecks from securing quality starting materials, quality by design, and automated large-scale manufacturing, to ultimately reduce costs of mRNA production while harmonizing with regulatory expectations. |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。